Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Seretide MDI submitted for European marketing approval

Dec. 17, 1999

Dual NK1/NK2 antagonists from HMR useful for asthma and related disorders

Dec. 17, 1999

PathoGenesis's TOBI approved in the U.K.

Dec. 17, 1999

AstraZeneca files for new asthma combination product in Sweden

Dec. 16, 1999

Successful phase II trial of Milkhaus cystic fibrosis product

Dec. 14, 1999

Chinese university researchers design new series of bronchodilators

Dec. 14, 1999

PPL Therapeutics announces promising preliminary data from AAT deficiency trial

Dec. 13, 1999

Zambon initiates phase II trial of Sheffield's MSI albuterol

Dec. 13, 1999

Antiasthmatic compounds from Otsuka bind to adenosine A3 receptors

Dec. 9, 1999

Nasonex Nasal Spray approved for new pediatric indication in U.S.

Dec. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...